Tag: Obesity
Recent Decade Saw Rise in Number of Adults With Severe Obesity
Additionally, small increases seen in the percentage of children and adolescents with obesity
Many With Overweight, Obesity Discontinue GLP-1 Receptor Agonists Within One Year
Higher discontinuation rates and lower reinitiation rates seen for those without type 2 diabetes
Ultraprocessed Food Consumption in Early Childhood Tied to Obesity
Findings primarily seen in male children with anthropometric adiposity measured at age 5 years
Metabolic Surgery May Be Beneficial in MASH-Related Cirrhosis, Obesity
Significantly lower 15-year cumulative incidence of major adverse liver outcomes seen in those undergoing metabolic surgery
Diabetes Remission Increased With Dapagliflozin Plus Calorie Restriction
Dapagliflozin plus calorie restriction beneficial for patients with overweight or obesity and type 2 diabetes
Several Factors Play Role in Semaglutide Initiation for Obesity Without Diabetes
Female sex, antidepressant use, and type of health insurance significantly influence semaglutide initiation
Global Commission Presents Nuanced Approach for Defining Clinical Obesity
Clinical obesity defined as chronic illness resulting from effect of excess adiposity on organ and tissue function
Obesity at Pediatric Cancer Diagnosis Linked to Inferior Survival
Inferior event-free and overall survival seen for patients with obesity, especially children with ALL and CNS tumors
GLP-1 RAs Efficacious for Weight Loss in Overweight, Obesity Without Diabetes
Adverse events were frequent, and most were gastrointestinal-related, including nausea, vomiting, diarrhea, constipation
Disparities Exist in Use of Obesity-Management Medications
Findings show lower use among Black, Hispanic, and Asian adults versus White adults
